Company Registration No. 9730063 (England and Wales)
ADIL MED LTD
Unaudited accounts
for the year ended 31 August 2024
ADIL MED LTD
Unaudited accounts
Contents
ADIL MED LTD
Company Information
for the year ended 31 August 2024
Director
Mohammad Adil Amini
Company Number
9730063 (England and Wales)
Registered Office
805 LEEDS ROAD
BRADFORD
BD3 8BY
UNITED KINGDOM
ADIL MED LTD
Statement of financial position
as at 31 August 2024
Cash at bank and in hand
911
2,169
Creditors: amounts falling due within one year
(1,629)
(1,828)
Net current (liabilities)/assets
(519)
341
Total assets less current liabilities
(70)
939
Provisions for liabilities
Net (liabilities)/assets
(184)
825
Called up share capital
100
100
Profit and loss account
(284)
725
Shareholders' funds
(184)
825
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 4 January 2025 and were signed on its behalf by
Mohammad Adil Amini
Director
Company Registration No. 9730063
ADIL MED LTD
Notes to the Accounts
for the year ended 31 August 2024
ADIL MED LTD is a private company, limited by shares, registered in England and Wales, registration number 9730063. The registered office is 805 LEEDS ROAD, BRADFORD, BD3 8BY, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the year ended 31 August 2024 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 September 2022.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Computer equipment
ADIL MED LTD
Notes to the Accounts
for the year ended 31 August 2024
Amounts falling due within one year
6
Creditors: amounts falling due within one year
2024
2023
Taxes and social security
-
199
Loans from directors
1,509
1,509
7
Average number of employees
During the year the average number of employees was 0 (2023: 0).